Abdominothoracic Muscular Tone in Functional Dyspepsia
- Conditions
- Dyspepsia
- Interventions
- Behavioral: Abdominothoracic biofeedback
- Registration Number
- NCT05417204
- Brief Summary
Background. Patients with functional dyspepsia report symptoms after eating without detectable cause. A recent proof-of-concept study demonstrated that in healthy subjects, the activity of the abdominal walls influences perception of digestive sensations, specifically, intentional abdominal distension (by a maneuver of diaphragmatic contraction) increased bloating sensation in response to a probe meal.
Aim. To determine the role of the abdominothoracic muscular activity on symptoms of functional dyspepsia.
Design. Parallel study in dyspeptic patients who have an abnormal somatic response to a probe meal (experimental group), and patients who do not (control group), comparing the effect of abdominophrenic biofeedback on dyspeptic symptoms. The probe meal will consist in stepwise ingestion of a comfort meal (hot ham and cheese sandwich plus orange juice) up to maximal satiation.
Intervention. A standard biofeedback technique (3 sessions over a 4-week period) directed at controlling the muscular activity (postural tone) of the abdominal walls, will serve as active intervention in the experimental group, and as a sham intervention in the control (active comparator) group.
The study outcomes will be measured before, immediately after and at 6 months after biofeedback: 1) Clinical symptoms measured by scales during 7 consecutive days. 2) Responses to the probe meal: (a) sensations measured by scales; (b) changes in girth by adaptive belts; (c) diaphragmatic position by abdominal ultrasound.
Relevance. The identification of a pathophysiological mechanism of dyspeptic symptoms could serve as an objective marker for diagnosis and as a target for the development of mechanistic treatments.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
- Rome IV Criteria for functional dyspepsia
- organic gastrointestinal diseases
- obesity
- history of anosmia and ageusia
- alcohol abuse
- eating disorders
Age- and-sex-matched healthy subjects will be included in parallel to the 30 first patients, to determine the normal values of the response to the probe meal. Healthy subjects will not undergo the intervention.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Correction of abnormal somatic response to a meal Abdominothoracic biofeedback Biofeedback in patients with functional dyspepsia and abnormal somatic response to a probe meal Sham intervention in patients with normal somatic response to a meal Abdominothoracic biofeedback Biofeedback in patients with functional dyspepsia and normal somatic response to a probe meal
- Primary Outcome Measures
Name Time Method Postprandial fullness 7 days Change in postprandial fullness (measured on daily postprandial fullness scales graded from 0, i.e., not at all, to 10, i.e., extremely severe) during 7 consecutive days before and immediately after intervention.
- Secondary Outcome Measures
Name Time Method Tolerance of a probe meal 60 minutes Change in the amount of a probe meal tolerated (Kcal consumed) before and after intervention.
Abdominal distension in response to a probe meal 60 minutes Changes in the girth response to a probe meal (measured by adaptive belts) before and after intervention.
Digestive well-being after a probe meal 60 minutes Change in digestive well-being after a probe meal (measured on a scale graded from -5, i.e., extremely negative, to +5, i.e., extremely positive) before and after intervention
Postprandial fullness after a probe meal 60 minutes Change in postprandial fullness after a probe meal (measured on a scale graded from 0, i.e., not at all, to 10, i.e., extremely severe) before and after intervention
Diaphragmatic response to a probe meal 60 minutes Changes in the diaphragmatic response to a probe meal (measured by ultrasound) before and after intervention.
Trial Locations
- Locations (1)
Hospital Vall d'Hebron
🇪🇸Barcelona, Spain